Log in


Diagnostic Approach to autoimmune encephalitis

Eoin P. Flanagan, M.B, B.Ch
Mayo Clinic - Rochester

Recording: the recording will be available after October 24th

Duration: 1 hour

Evaluation: the session evaluation will be available after October 24th

Back to conference landing page

Learning Objectives

By the end of this session, attendees will be able to:

  1. Recognize the clinical manifestations of autoimmune encephalitis.
  2. Understand the utility ad pitfalls of neural autoantibody testing.
  3. Appreciate the novel settings in which autoimmune encephalitis is arising.

Summary

This presentation will review the clinical, radiologic, spinal fluid, and antibody associations of autoimmune encephalitis.  It will also briefly highlight the treatment approach ad prognosis.  The presentation will update participants on autoimmune encephalitis arising in novel settings.

Handouts

Presentation handouts will be available after October 24th

Speaker Bio


Dr. Eoin Flanagan is an Associate Professor of Neurology and Consultant in the departments of Neurology and Laboratory Medicine and Pathology at the Mayo Clinic (Rochester, MN). He completed his medical school training at University College Dublin in Ireland in 2005. He completed medical residency in Ireland and became a member of the Royal College of Physicians of Ireland in 2008. He then pursued neurology residency at Mayo Clinic (Rochester, MN) and is board certified in neurology in the USA. He completed fellowships in autoimmune neurology, multiple sclerosis and behavioral neurology at Mayo Clinic. He received a Master’s degree in clinical and translational science at Mayo Clinic. He works in the Autoimmune and Multiple Sclerosis Neurology Clinics and the Neuroimmunology Laboratory at the Mayo Clinic. His clinical expertise and research is focused on the diagnosis and management of autoimmune neurological disorders with an emphasis on inflammatory autoimmune spinal cord disorders and their mimics including their MRI patterns. He also has an interest in the epidemiology of inflammatory demyelinating diseases of the central nervous system and autoimmune neurologic disorders.

Powered by Wild Apricot Membership Software